The NADAL® COVID-19 IgG/IgM Test is a lateral flow chromatographic immunoassay for the qualitative detection of anti-SARS-CoV-2 IgG and IgM in human whole blood, serum or plasma specimens.
Note that in the early stages of infection (3 to 7 days after the onset of symptoms) anti-SARS-CoV-2 IgG and IgM may be below the detection limit of the test. The test procedure is not automated and requires no special training or qualification. The NADAL® COVID-19 IgG/IgM Test is designed for professional use only.
Holding the pipette vertically, draw the serum or plasma sample up to the first widening (approx. 5 μL) and dispense it into the sample well(S) of the test cassette.
Holding the pipette vertically, dispense 1 drop (approx. 10μL) of the whole blood sample into the specimen well(S) of the test cassette.
Holding the buffer bottle vertically, dispense 2 drops of buffer into the sample well(S) of the test cassette. Avoid the formation of air bubbles.
Wait until the coloured line(s) appear(s). Read the test result after exactly 15 minutes.
Rapid test for the detection of anti-SARS-CoV-2 IgG and IgM in human whole blood, serum or plasma samples
|Product||Sample material||Sensitivity||Specificity||Product code||Pack size|
|NADAL® COVID-19 IgG/IgM Rapid Test||Whole blood, serum or plasma samples||IgM: 93.7 %
IgG: 98.8 %
|IgM: 99.1 %
IgG: 98.7 %
|243003N-25||25 tests per pack|